Stock 2E40 PHAXIAM THERAPEUTICS S.A.
Add to a list
To use this feature you must be a member
Log inSign up

All News PHAXIAM Therapeutics S.A. Deutsche Boerse AG

Equities

2E40

FR001400K4B1

Market Closed - Deutsche Boerse AG
Other stock markets
 20:41:05 28/06/2024 BST 		5-day change 1st Jan Change
1.89 EUR -9.79% Intraday chart for PHAXIAM Therapeutics S.A. -3.57% -57.53%
06-28 Would you like some more inflation? Our Logo
06-28 Phaxiam: fewer funds raised than expected CF

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PHAXIAM Therapeutics S A : announces the success of its rights issue of €7.8m
PU
Results of the Combined General Meeting of 28 June 2024
GL
Results of the Combined General Meeting of 28 June 2024
AQ
Would you like some more inflation?
Our Logo
Phaxiam: fewer funds raised than expected
CF
Phaxiam: capital increase of ten million euros
CF
PHAXIAM announces the availability of the preparatory documents for the Combined General Meeting of 28 June 2024
GL
PHAXIAM provides Business and Financial Update for the First Quarter of 2024
GL
Phaxiam initiates trial in infective endocarditis
CF
PHAXIAM Therapeutics announces enrolment of the first patient in the phase 1 study for the treatment of endocarditis infections caused by Staphylococcus aureus
GL
PHAXIAM Therapeutics Announces Enrolment of First Patient in the Phase 1 Study for the Treatment of Endocarditis Infections Caused by Staphylococcus Aureus
CI
PHAXIAM Therapeutics announces filing of its 2023 Universal Registration Document (URD)
GL
Transcript : PHAXIAM Therapeutics S.A., Q4 2023 Earnings Call, Mar 21, 2024
PHAXIAM Announces 2023 Full-Year Results and Provides Business Update
GL
PHAXIAM Therapeutics S.A. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
PHAXIAM Therapeutics Completes Delisting of ADS From Nasdaq
MT
Phaxiam Therapeutics Delists from Nasdaq Capital Market
MT
PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market
GL
PHAXIAM Therapeutics S.A.(NasdaqCM:PHXM) dropped from NASDAQ Composite Index
CI
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3%
DJ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. PHXM Stock
  4. 2E40 Stock
  5. News PHAXIAM Therapeutics S.A.